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Background: BBTMH-007, Derived from the black bean, is high in anti-oxidants and decreases fibrosis in an animal model of cirrhosis. This study 
aims to characterize the effects of BBTMH-007 in a model of acute cardiomyopathy.
Methods: In vitro studies used cardiac derived fibroblasts stimulated with 10% fetal calf serum (FCS) with/without BBTMH-007 followed by real-
time PCR. In vivo studies used young C57BL6 mice which receive L-NAME and NaCl in their drinking water. Angiotensin II is administered for the final 
4 weeks. BBTMH-007 extract was incorporated into the food. Experiments were repeated 5 times in series.
Results: In vitro experiments show attentuation of the FCS induced collagen I and TGF-b in the cardiac fibroblasts. In vivo, CM mice demonstrated 
increased body weight while mice treated with BBTMH-007 did not. Both BNP and ET-1 were increased in CM versus control mice while BBTMH-007 
blocked the increase in both. Decreases in cardiac interstitial fibrosis in the BBTMH-007 treated group were significant as well as a decrease in 
TGF-b and a decrease in inflammatory cells in the heart. The BBTMH-007 treated mice demonstrated decreased hypertrophy (LVIDd) as measured by 
MRI. Mortality in CM mice was 20% at the end of the protocol while the BBTMH007 treated mice had 0% mortality.
Conclusions: BBTMH-007 demonstrates blockade of cardiac fibrosis and preserved cardiac function in a model of acute cardiomyopathy. The 
mechanism of action may in part be mediated by specific effects on cardiac fibroblast function.
